GERN Announcement: For Securities Inquiries, Reach Out to Kessler Topaz Meltzer & Check, LLP

A class action lawsuit for securities fraud has been filed against Geron Corporation (GERN), prompting investors to seek legal counsel with Kessler Topaz Meltzer & Check, LLP. The lawsuit alleges that Geron made false and misleading statements regarding its drug, imetelstat, and its potential to treat myelofibrosis, a rare type of bone marrow cancer. Investors who purchased Geron stock between March 19, 2018, and September 26, 2018, may be eligible to join the class action lawsuit.

The lawsuit claims that Geron failed to disclose key information to investors, leading them to believe that imetelstat was closer to receiving FDA approval than it actually was. This alleged withholding of information caused Geron’s stock price to be artificially inflated, misleading investors to invest in the company at an inflated price. When the truth about imetelstat’s FDA approval status was revealed, Geron’s stock price plummeted, resulting in financial losses for investors.

Kessler Topaz Meltzer & Check, LLP is investigating claims on behalf of investors who suffered losses from investing in Geron during the specified time period. Investors who wish to join the class action lawsuit are encouraged to contact the law firm to discuss their legal options and rights. The law firm has a history of successfully representing investors in similar securities fraud cases and is dedicated to seeking justice for those who have been financially harmed by misleading information from corporations.

The class action lawsuit against Geron Corporation highlights the importance of due diligence and transparency in the securities market. Investors rely on accurate and truthful information to make informed decisions about their investments. When companies fail to disclose material information or make false statements, investors can suffer significant financial losses. Legal action, such as a class action lawsuit, can hold companies accountable for their actions and provide a path to recover losses for affected investors.

Investors who believe they may be eligible to participate in the securities fraud class action lawsuit against Geron Corporation should seek legal guidance from experienced attorneys like those at Kessler Topaz Meltzer & Check, LLP. By joining forces with other investors in a class action lawsuit, individuals can collectively seek justice and potentially recover financial losses incurred as a result of misleading statements or omissions by Geron. It is essential for investors to be aware of their rights and options when faced with potential securities fraud, and seeking legal advice is a crucial step in pursuing a resolution to their claims.